Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
TEVA Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
TEVA Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
TEVA deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 6,622,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 8,468,000,000 | |
| 8,976,000,000 | |
| 8,702,000,000 | |
| 368,000,000 | |
| 9,645,000,000 | |
| 10,060,000,000 | |
| 10,649,000,000 | |
| 11,444,000,000 | |
| 10,957,000,000 | |
| 11,035,000,000 | |
| 10,660,000,000 | |
| 12,103,000,000 | |
| -4,953,000,000 | |
| -3,855,000,000 | |
| -3,528,000,000 | |
| 735,000,000 | |
| -2,964,000,000 | |
| -2,976,000,000 | |
| -3,036,000,000 | |
| 993,000,000 | |
| -2,894,000,000 | |
| -3,026,000,000 | |
| 1,034,000,000 | |
| 1,084,000,000 | |
| -3,049,000,000 | |
| -3,107,000,000 | |
| -3,144,000,000 | |
| 1,142,000,000 | |
| -3,097,000,000 | |
| 0 | |
| 0 | |
| 2,610,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,348,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,741,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,723,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 486,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 212,300,000 | |
| 0 | |
| 226,700,000 | |
| 0 | |
| 34,600,000 | |
| 36,600,000 | |
| 0 | |
| 0 | |
| 43,700,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |